Craig B. Granowitz
SVP, Chief Medical Officer, Lexicon Pharmaceuticals.
Companies
- Lexicon PharmaceuticalsSVP, Chief Medical Officer Aug 3, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexicon Pharmaceuticals LXRX323,430 shares2$506.2K at $1.56Feb 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2026Shares withheld for tax 109,098 shares at $1.47 of Lexicon Pharmaceuticals2
- Feb 28, 2026Exercised options 202,260 shares of Lexicon Pharmaceuticals2
- Feb 28, 2026Exercised options 74,226 shares of Lexicon Pharmaceuticals2
- Feb 28, 2026Exercised options 35,790 shares of Lexicon Pharmaceuticals2
- Feb 28, 2025Shares withheld for tax 65,308 shares at $0.67 of Lexicon Pharmaceuticals3
- Feb 28, 2025Exercised options 74,227 shares of Lexicon Pharmaceuticals3
- Feb 28, 2025Exercised options 35,790 shares of Lexicon Pharmaceuticals3
- Feb 28, 2025Exercised options 27,917 shares of Lexicon Pharmaceuticals3
- Feb 28, 2024Shares withheld for tax 31,265 shares at $2.62 of Lexicon Pharmaceuticals4
- Feb 28, 2024Exercised options 35,790 shares of Lexicon Pharmaceuticals4
- Feb 28, 2024Exercised options 27,916 shares of Lexicon Pharmaceuticals4
- Feb 28, 2023Shares withheld for tax 12,732 shares at $2.17 of Lexicon Pharmaceuticals5
- Feb 28, 2023Exercised options 27,917 shares of Lexicon Pharmaceuticals5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 3, 2025
- 4SEC EDGARForm 4 filed Feb 29, 2024
- 5SEC EDGARForm 4 filed Mar 1, 2023